Mitsubishi UFJ Asset Management Co., Ltd. - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 251 filers reported holding FATE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.

Quarter-by-quarter ownership
Mitsubishi UFJ Asset Management Co., Ltd. ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$127,834
-48.7%
60,299
+15.1%
0.00%
-100.0%
Q2 2023$249,343
+245.8%
52,383
+314.1%
0.00%
Q1 2023$72,099
-44.0%
12,6490.0%0.00%
Q4 2022$128,640
-48.1%
12,649
+14.4%
0.00%
-100.0%
Q3 2022$248,000
-9.5%
11,052
-0.2%
0.00%0.0%
Q2 2022$274,000
+26.9%
11,071
+99.1%
0.00%0.0%
Q1 2022$216,000
-31.4%
5,560
+6.3%
0.00%0.0%
Q4 2021$315,000
+29.1%
5,230
+27.2%
0.00%0.0%
Q3 2021$244,000
-31.7%
4,1110.0%0.00%
-50.0%
Q2 2021$357,000
-39.5%
4,111
-42.6%
0.00%
-50.0%
Q1 2021$590,000
+34.4%
7,158
+48.1%
0.00%
+33.3%
Q4 2020$439,000
+64.4%
4,833
-27.6%
0.00%
+50.0%
Q3 2020$267,000
+16.1%
6,676
-0.6%
0.00%
-33.3%
Q2 2020$230,000
-15.4%
6,718
-45.2%
0.00%
-25.0%
Q1 2020$272,000
+45.5%
12,255
+25.4%
0.00%
+100.0%
Q4 2019$187,000
+54.5%
9,775
+25.0%
0.00%0.0%
Q3 2019$121,000
-5.5%
7,820
+24.3%
0.00%0.0%
Q2 2019$128,000
-42.3%
6,291
-50.2%
0.00%
-60.0%
Q1 2019$222,000
+47.0%
12,624
+9.9%
0.01%
+25.0%
Q4 2018$151,000
-36.6%
11,485
-21.3%
0.00%
-20.0%
Q3 2018$238,00014,6010.01%
Other shareholders
FATE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$34,0959.92%
Redmile Group, LLC 12,957,222$130,738,3705.35%
GCM Grosvenor Holdings, LLC 1,037,256$10,465,9132.67%
Casdin Capital, LLC 2,050,000$20,684,5001.60%
DAFNA Capital Management LLC 550,940$5,558,9851.57%
Artal Group S.A. 2,600,000$26,2341.46%
Monaco Asset Management SAM 250,000$2,522,5000.76%
Parametrica Management Ltd 32,254$325,4430.67%
Boxer Capital, LLC 1,250,000$12,612,5000.66%
Bellevue Group AG 4,861,279$49,050,3050.65%
View complete list of FATE THERAPEUTICS INC shareholders